Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M E Davis

Showing results (151-160 of 349) with videos related to

Pageof 35
Sort By:
Plos One|December 11, 2013
Clinical impact of the temporal relationship between depression and type 2 diabetes: the Fremantle diabetes study phase IIDavid G Bruce, Wendy A Davis, Violetta Cetrullo, et al.
Internal Medicine Journal|October 11, 2020
Differences in retinopathy prevalence and progression between Anglo-Celt and Aboriginal Australians: the Fremantle Diabetes Study Phase IIJocelyn J Drinkwater, Wendy A Davis, Angus W Turner, et al.
Diabetes Research and Clinical Practice|July 17, 2020
Complementary and alternative medicine beliefs in type 2 diabetes: The Fremantle Diabetes Study Phase IIImrana Sharif, Tatsiana Yarash, Farhat Masood, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 7, 2025
Characteristics of Dyslipidemia in Adults With Resistance to Thyroid Hormone βTimothy M E Davis, Wendy A Davis, Carla Moran, et al.
Depression and Anxiety|May 11, 2016
Comorbid Anxiety and Depression and Their Impact on Cardiovascular Disease in Type 2 Diabetes: The Fremantle Diabetes Study Phase IIDavid G Bruce, Wendy A Davis, Milan Dragovic, et al.
The American Journal of Tropical Medicine and Hygiene|July 24, 2002
Relative bioavailability of artesunate and dihydroartemisinin: investigations in the isolated perfused rat liver and in healthy Caucasian volunteersKevin T Batty, Kenneth E Iletr, Shane M Powell, et al.
Antimicrobial Agents and Chemotherapy|August 19, 2006
Role of P glycoprotein in absorption of novel antimalarial drugsAndrew Crowe, Kenneth F Ilett, Harin A Karunajeewa, et al.
Diabetes Research and Clinical Practice|June 8, 2018
The relationship between intensification of blood glucose-lowering therapies, health status and quality of life in type 2 diabetes: The Fremantle Diabetes Study Phase IITimothy M E Davis, David G Bruce, Bradley H Curtis, et al.
Plos One|March 16, 2018
The utility of the Diabetes Anxiety Depression Scale in Type 2 diabetes mellitus: The Fremantle Diabetes Study Phase IIWendy A Davis, David G Bruce, Milan Dragovic, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 10, 2012
Simultaneous determination of primaquine and carboxyprimaquine in plasma using solid phase extraction and LC-MS assayMadhu Page-Sharp, Kenneth F Ilett, Inoni Betuela, et al.
Pageof 35

Showing results (151-160 of 349) with videos related to

Sort By:
Pageof 35
Plos One|December 11, 2013
Clinical impact of the temporal relationship between depression and type 2 diabetes: the Fremantle diabetes study phase IIDavid G Bruce, Wendy A Davis, Violetta Cetrullo, et al.
Internal Medicine Journal|October 11, 2020
Differences in retinopathy prevalence and progression between Anglo-Celt and Aboriginal Australians: the Fremantle Diabetes Study Phase IIJocelyn J Drinkwater, Wendy A Davis, Angus W Turner, et al.
Diabetes Research and Clinical Practice|July 17, 2020
Complementary and alternative medicine beliefs in type 2 diabetes: The Fremantle Diabetes Study Phase IIImrana Sharif, Tatsiana Yarash, Farhat Masood, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 7, 2025
Characteristics of Dyslipidemia in Adults With Resistance to Thyroid Hormone βTimothy M E Davis, Wendy A Davis, Carla Moran, et al.
Depression and Anxiety|May 11, 2016
Comorbid Anxiety and Depression and Their Impact on Cardiovascular Disease in Type 2 Diabetes: The Fremantle Diabetes Study Phase IIDavid G Bruce, Wendy A Davis, Milan Dragovic, et al.
The American Journal of Tropical Medicine and Hygiene|July 24, 2002
Relative bioavailability of artesunate and dihydroartemisinin: investigations in the isolated perfused rat liver and in healthy Caucasian volunteersKevin T Batty, Kenneth E Iletr, Shane M Powell, et al.
Antimicrobial Agents and Chemotherapy|August 19, 2006
Role of P glycoprotein in absorption of novel antimalarial drugsAndrew Crowe, Kenneth F Ilett, Harin A Karunajeewa, et al.
Diabetes Research and Clinical Practice|June 8, 2018
The relationship between intensification of blood glucose-lowering therapies, health status and quality of life in type 2 diabetes: The Fremantle Diabetes Study Phase IITimothy M E Davis, David G Bruce, Bradley H Curtis, et al.
Plos One|March 16, 2018
The utility of the Diabetes Anxiety Depression Scale in Type 2 diabetes mellitus: The Fremantle Diabetes Study Phase IIWendy A Davis, David G Bruce, Milan Dragovic, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 10, 2012
Simultaneous determination of primaquine and carboxyprimaquine in plasma using solid phase extraction and LC-MS assayMadhu Page-Sharp, Kenneth F Ilett, Inoni Betuela, et al.
Pageof 35